Clinical trial
Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers
NCT00416845 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00416845 |
|---|---|
| Title | Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers |
| Official title | A Randomized, Parallel Group, Double-blind, Placebo Controlled, 14 Days Multiple-dose Treatment to Assess the Pulmonary and Cardiac Pharmacodynamics of FTY720 (0.5 and 1.25 mg) in Healthy Volunteers |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | FTY720 |
| Enrollment | 39 |
| Start date | Oct 1, 2006 |
| Primary completion | Mar 1, 2007 |
| First posted | Dec 28, 2006 |
| Last update posted | Jun 4, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: